Dr. Ananya Mandal, MD A team of researchers has created beating heart cells in the lab using skin cells of children with a rare heart defect. The team, led by Ricardo Dolmetsch of Stanford University took skin cells from children with Timothy syndrome, a rare heart condition commonly associated with autism, as well as syndactyly [...]
Texas Heart Institute researcher, Emerson Perin MD, PhD revealed that heart patients who were treated with bone marrow-derived adult stem cells died at a significantly lower rate that those who did not receive stem cells. Dr. Perin's scientific findings represent yet another positive step in the ongoing fight against heart disease. Dr. Perin is the [...]
The clinical trial, Non-Revascularizable IschEmic Cardiomyopathy treated with Retrograde COronary Sinus Venous DElivery of Cell TheRapy (RECOVER-ERC), is being led by Principle Investigator Dr. Leo Bockeria, Chairman of the Backulev Center http://www.bakulev.ru/en/about/director/. The Backulev Center is Russia's premier institute for cardiovascular surgery and cardiology. Every year the Backulev Center performs approximately 30,000 diagnostic and treatment [...]
Excerpts from Interview with Dr. Amit Patel, Director of Regenerative Medicine, University of Utah by Thomas Ichim, Ph.D, CEO of Medistem Inc
www.thelatestwith.com Ichim: Which one was the first stem cell trial for cardiac conditions? Patel: It is like one of those questions like who did the first heart operation. There is a lot of debate as to what was the first to use cells plus therapy and there have been a number of trials. Myoblasts were [...]
A Number of Clinical Trials Using Adult Stem Cells Are Showing Early Success Dozens of adult stem cell treatments are moving through clinical trials and showing early success, raising hopes that some could reach the market within five years. 'It will only take a few successes to really change the field,' said Gil Van Bokkelen, [...]
Cardiology Today PRECISE is The Randomized Clinical Trial of Adipose-Derived Stem Cells in Treatment of Non Revascularizable Ischemic Myocardium, a double blind, placebo-controlled trial involving 27 patients with chronic ischemic heart disease with HF, angina or both, who were not eligible for percutaneous or surgical revascularization. The patients in the study underwent a liposuction to [...]
Cardiac medicine has traditionally been associated with innovative procedures that sometimes where considered heretical to the present day dogma. For example, the first heart transplant, the use of the balloon catheter, the introduction of thrombolytics, all met substantial resistance from the “establishment” in their time. It appears that the next revolution in cardiac medicine is [...]
Stem Cell Institute in Panama Collaborates on New Method of Treating Diabetes-Associated Heart Disease
Zhang et al. Journal of Translational Medicine Diabetes is associated with numerous “secondary complications” including premature heart disease, renal failure, critical limb ischemia (an advanced form of peripheral artery disease) and diabetic retinopathy. One of the common features of these secondary complications is that they are all associated with low levels of circulating endothelial progenitor [...]
Among this year's recipients of the Lasker Awards are Dr. Shinya Yamanaka of Kyoto University in Japan and Dr. John Gurdon of Cambridge University in England.
The U.S. company Neuralstem receives yet another patent for its novel adult stem cell technology.